Alps Dx Launches to Modernize Oral Fluid Drug Testing Through Connected Pre-Analytical Automation
RICHMOND, Va., Jan. 7, 2026 /PRNewswire/ -- Alps Dx today announced its official launch as an innovative diagnostics tooling and...
Search Trends
Behind the Relapse No One Saw Coming: How First Ascent Biomedical Is Changing Cancer Treatment Decisions
Logan Jenner, a five-year-old battling acute myeloid leukemia, found new hope through a clinical trial that used Functional Precision Medicine...
Best CBD Gummies 2026 Consumer Report: Full Spectrum Formulations, Lab Testing Standards, and State Legal Requirements Examined in Consumer Wellness Category Analysis
As January 2026 wellness searches peak, this consumer education analysis examines how informed buyers evaluate CBD gummies for sleep and...
Best BPC-157 Oral Supplements: ProHealth’s Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026
36-Year Company's Oral Capsule Format vs. Injectable BPC-157: Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status ExaminedCARPINTERIA, Dec. 23, 2025...
Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring
Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing...
Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring
Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing...
CORRECTION: Pluristyx Launches Organoid COMMONS, Uniting Industry Leaders to Revolutionize Drug Discovery
Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing...
Pluristyx Launches Organoid COMMONS, Uniting Industry Leaders to Revolutionize Drug Discovery
Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing...
Rebuilding the Tumor Microenvironment for In Vitro Discovery, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery. Attendees...
Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...
Disruption in Cancer Care: How Jim Foote’ AI is Revolutionizing Oncology
Jim Foote, CEO of First Ascent Biomedical, is revolutionizing cancer care with an AI-driven, functional precision medicine platform. Inspired by...
Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in...
Digital Health Breakthrough: AI-Powered Remote Drug Testing Removes Barriers to Recovery
BOSTON, Sept. 16, 2025 /PRNewswire/ -- Q2i today announced a collaboration with King's College London (King's) to evaluate its AI-powered...
Haven House Sober Living Nominated for Best Luxury Sober Living in Los Angeles 2025
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Haven House Sober Living has been nominated for Best...
Neopharma Technologies and Orient Gene Partner to Digitize Healgen® Drug Test Portfolio Globally with NEOVAULT®
Partnership delivers tamper-evident, high-integrity testing data aligned with U.S. Drug Policy Priorities WASHINGTON, Aug. 25, 2025 /PRNewswire/ -- Neopharma Technologies...
Biolabs International’s New App Cuts Clinic Visits, Expands Testing Access
Biolabs' CONNECTED DIAGNOSTICS App and decentralized clinical trial platform integrates rapid diagnostic testing, artificial intelligence, and telehealth, all accessible from a smartphone...
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growthNEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio...
Bill Corl of Omega Laboratories Joins Cannabix Technologies Board of Directors
VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the...
Neopharma Technologies Appoints Exchange Listing to Manage U.S. IPO
NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Neopharma Technologies Ltd (NTL), a leading MedTech company specializing in digital drug and...
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...